alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
---

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of China Kangtai Cactus
Bio-Tech, Inc. (the "Company") on Form 10-K for the fiscal year ended December
31, 2010 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Hong Bu, certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the
Company.

Date: March ___, 2011

/s/ Hong
BuHong Bu, Principal Financial and Accounting Officer

---
Exhibit 24

                                POWER OF ATTORNEY

                       REMINGTON PRODUCTS COMPANY, L.L.C.




     KNOW ALL MEN BY THESE  PRESENTS,  that each person whose name appears below
constitutes and appoints  Alexander R. Castaldi,  and Kris J. Kelley and each of
them,  his true and  lawful  attorneys-in-fact  and  agents,  with full power of
substitution  and  resubstitution,  for and in his name, place and stead, in any
and all  capacities  which  such  person  serves or may serve  with  respect  to
Remington  Products  Company,  L.L.C.  and Remington  Capital Corp., to sign the
Annual Report on Form 10-K of Remington  Products Company,  L.L.C. and Remington
Capital  Corp.  for the fiscal  year ended  December  31,  2000,  and any or all
amendments  to such  Annual  Report,  and to file the  same,  with all  exhibits
thereto,  and other documents in connection  therewith,  with the Securities and
Exchange Commission,  granting unto said  attorneys-in-fact and agents, and each
of them, full power and authority to do and perform each and every act and thing
requisite and  necessary to be done in and about the  premises,  as fully to all
intents and  purposes as he might or could do in person,  hereby  ratifying  and
confirming all that said  attorneys-in-fact  and agents or any of them, or their
or his substitutes, may lawfully do or cause to be done by virtue hereof.

This power of attorney has been signed as of the ____ day of March, 2001, by the
following persons:


-----------------------------------         ------------------------------------
Neil P. DeFeo,                              Victor K. Kiam, II,
Chief Executive Officer, President          Chairman and Director
 and Director


-----------------------------------         ------------------------------------
Victor K. Kiam, III, Director               Robert L. Rosner, Director


-----------------------------------         ------------------------------------
Norman W. Alpert, Director                  Kevin Mundt, Director


-----------------------------------         ------------------------------------
Arthur J. Nagle,  Director                  Daniel S. O'Connell, Director


-----------------------------------         ------------------------------------
William B. Connell, Director                Steven M. Silver, Director


-----------------------------------         -----------------------------------
Stephen P. Donovan, Director                Kris J. Kelley
                                            Vice President and Controller

-----------------------------------
Alexander R. Castaldi,
Executive Vice President, Chief Financial
    and Administrative Officer
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 15-6437

DONALD FREDERICK SAUER,

Petitioner - Appellant,

v.

BUTCH JACKSON,

Respondent - Appellee.

Appeal from the United States District Court for the Eastern 

District of North Carolina, at Raleigh. James C. Fox, Senior 

District Judge. (5:13-hc-02079-F)

Submitted: August 28, 2015 Decided: September 9, 2015

Before NIEMEYER and THACKER, Circuit Judges, and DAVIS, Senior 

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Bruce Tracy Cunningham, Jr., LAW OFFICE OF BRUCE T. CUNNINGHAM, 

JR., Southern Pines, North Carolina, for Appellant. Clarence 

Joe DelForge, III, NORTH CAROLINA DEPARTMENT OF JUSTICE, 

Raleigh, North Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Donald Frederick Sauer seeks to appeal the district court’s 

order denying relief on his 28 U.S.C. § 2254 (2012) petition. 

The order is not appealable unless a circuit justice or judge 

issues a certificate of appealability. 28 U.S.C. 

§ 2253(c)(1)(A) (2012). A certificate of appealability will not 

issue absent “a substantial showing of the denial of a 

constitutional right.” 28 U.S.C. § 2253(c)(2) (2012). When the 

district court denies relief on the merits, a prisoner satisfies 

this standard by demonstrating that reasonable jurists would 

find that the district court’s assessment of the constitutional 

claims is debatable or wrong. Slack v. McDaniel, 529 U.S. 473, 

484 (2000); see Miller-El v. Cockrell, 537 U.S. 322, 336-38 

(2003). When the district court denies relief on procedural 

grounds, the prisoner must demonstrate both that the dispositive 

procedural ruling is debatable, and that the petition states a 

debatable claim of the denial of a constitutional right. Slack, 

529 U.S. at 484-85. 

We have independently reviewed the record and conclude that 

Sauer has not made the requisite showing. Accordingly, we deny 

a certificate of appealability, deny leave to proceed in forma 

pauperis, and dismiss the appeal. We dispense with oral 

argument because the facts and legal contentions are adequately 
3

presented in the materials before this court and argument would 

not aid the decisional process.

DISMISSED
IJNITED STATES OF AMERICA

U.S. DEPARTMENT OF HOMELAND SECURITY

UNITED STATES COAST GUARI)

UNITED STATES COAST GUARD

Complainant

NATAIJA DANISHA ACKIES

Respondent

Docket Numbq 2023-0007

Enforcement Activity No.76l l5l7

CONSENT ORDER APPROVING SETTLEMENT AGREEMENT

On January 9,2023,the parties in this case submitted a Motion for Approval of a

Settlement Agreement and Entry of Consent Order to be approved as a settlement oftle case

under 33 C.F.R. $ 20.502.

I have carefrrlly reviewed the terms of the Settlement Agreement and find that it is fair

and reasonable and in substantial compliance with the requirements of 33 C.F.R. $ 20.502.

ORDER

Upon consideration of record, it is hereby ORDERED that the Settlement Agreement is

APPROVED in flrll and incorporated herein by reference. This Consent Order shall constitute

flnL final, and complete adjudication ofthis proceeding.

Done and Dated January 19,2023 tt

New Orleans, LA

HON. BRIAN J. CT'RLEY

UNITED STATES COAST GUARI)

A.DMINISTRATIVE LAW JUDGE

vs.
---

EXHIBIT 32





CERTIFICATION PURSUANT TO





18 U.S.C. SECTION 1350,





AS ADOPTED PURSUANT TO





SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of PAID, INC. (the “Company”) on Form 10-K for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in their respective capacities as capacity as President and CEO of the Company and as CFO of the Company, certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





1.           The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





/s/ Gregory RotmanGregory RotmanPresident and CEOMarch 11, 2011/s/ Christopher R. CulrossChristopher R. CulrossChief Financial OfficerMarch 11, 2011
**EXHIBIT
      12.2**




I, **** David
      Zigdon, certify that:





1.
      I have
      reviewed this annual report on Form 20-F of RADCOM Ltd.;




2.
      Based
      on my knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;




3.
      Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the financial
      condition, results of operations and cash flows of the company as of, and for,
      the periods presented in this report;




4.
      The
      company’s other certifying officer(s) and I are responsible for establishing and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules
      13a-15(e) and 15d-15(e)) for the company and have:




(a)
      Designed such disclosure controls and procedures or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure that
      material information relating to the company, including its consolidated
      subsidiaries, is made known to us by others within those entities, particularly
      during the period in which this report is being prepared;




(b)
      Evaluated the effectiveness of the company’s disclosure controls and procedures
      and presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this
      report based on such evaluation; and




(c)
      Disclosed in this report any change in the company’s internal control over
      financial reporting that occurred during the period covered by the annual report
      that has materially affected, or is reasonably likely to materially affect,
      the
      company’s internal control over financial reporting; and




5.
      The
      company’s other certifying officer(s) and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the company’s
      auditors and the audit committee of the company’s board of directors (or persons
      performing the equivalent functions):




(a)
      All
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the company’s ability to record, process, summarize and report
      financial information; and




(b)
      Any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in the company’s internal control over financial
      reporting.




Date:
      March 29, 2006




/s/
      David Zigdon


David
      Zigdon


Chief
      Financial Officer


(Principal
      Financial Officer)
# C_2021350EN.01000101.xml

| 31.8.2021 | EN | Official Journal of the European Union | C 350/1 |
| --- | --- | --- | --- |

31.8.2021

EN

Official Journal of the European Union

C 350/1

---

Non-opposition to a notified concentration

(Case M.10415 — Black Diamond/Specialty Chemicals International)

(Text with EEA relevance)

(2021/C 350/01)

On 24 August 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10415. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10415. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
SMITH & MOREHOUSE RESERVOIRLatitude: 40.758Longitude: -111.104Elevation: 7722

SMITH & MOREHOUSE RESERVOIR

Courtesy NRCS - Go to Redden Mine Lwr Site Page...



Redden Mine Lwr

Courtesy NRCS - Go to Beaver Divide Site Page...



Beaver Divide

Courtesy NRCS - Go to Chalk Creek #1 Site Page...



Chalk Creek #1

Courtesy NRCS - Go to Smith  Morehouse Site Page...



Smith  Morehouse

Courtesy NRCS - Go to Trial Lake Site Page...



Trial Lake
Exhibit 32.2



PERICOM SEMICONDUCTOR CORPORATION



CERTIFICATION OF CHIEF FINANCIAL OFFICER



PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED



PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with this quarterly report of Pericom Semiconductor Corporation (the Company) on Form 10-Q for the three months ended December 25, 2004 (the
Report), I, Michael D. Craighead, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:



(1) the Report fully complies with the requirements of
Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and



(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.



February 8, 2005



By:

/s/ Michael D. CraigheadMichael D. CraigheadChief Financial OfficerPericom Semiconductor Corporation
EXHIBIT
      32.1




**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**








In
      connection with the quarterly report of eLinear, Inc. (the “Company”) on Form
      10-QSB for the quarter ended June 30, 2005, as filed with the Securities and
      Exchange Commission on the date hereof (the “Report”), I, Michael Lewis, Chief
      Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350,
      as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
      to
      the best of my knowledge:





(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.







/s/
      Michael
      Lewis


Michael
      Lewis,


Chief
      Executive Officer


August
      12, 2005


A
        signed
        original of this written statement required by Section 906 has been provided
        to
        eLinear, Inc. and will be retained by eLinear, Inc. and furnished to the
        Securities and Exchange Commission or its staff upon request.
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2021-N-0921]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA or Agency) is withdrawing approval of abbreviated new drug application (ANDA) BA110013/0032 for 6 Percent Hydroxyethyl Starch 130/0.4 in 0.9 Percent Sodium Chloride Injection in EXCEL® Plastic Container, held by B. Braun Medical, Inc. B. Braun Medical, Inc., requested in writing that the Agency's approval of the application be withdrawn because the drug is no longer being marketed and has waived its opportunity for a hearing.
 DATES: Approval is withdrawn as of October 22, 2021.
 FOR FURTHER INFORMATION CONTACT: Myrna Hanna, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240 402-7911.


SUPPLEMENTARY INFORMATION: B. Braun Medical Inc., 901 Marcon Blvd., Allentown, PA 18109, has requested that FDA withdraw approval of ANDA BA110013/0032, pursuant to § 314.150(c) (21 CFR 314.150(c)), because the drug is no longer being marketed. By its request, B. Braun Medical Inc. has also waived its opportunity for a hearing. Withdrawal of approval of an application under § 314.150(c) is without prejudice to refiling. Application No.
Proprietary nameANDA BA 110013/0032
6% Hydroxyethyl Starch 130/0.4 in 0.9% Sodium Chloride Injection in EXCEL® Plastic Container.
 Therefore, approval of the application listed in the table, and all amendments and supplements thereto, is hereby withdrawn as of October 22, 2021. Introduction or delivery for introduction into interstate commerce for products without an approved new drug application or ANDA violates section 301(a) and (d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331(a) and (d)). The drug product that is listed in the table above that is in inventory on October 22, 2021 may continue to be dispensed until the inventory has been depleted or the drug product has reached its expiration date or otherwise becomes violative, whichever occurs first. Dated: September 16, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy.


[FR Doc. 2021-20511 Filed 9-21-21; 8:45 am] BILLING CODE 4164-01-P
## In The

Court of Appeals

Sixth Appellate District of Texas at Texarkana

No. 06

- 13

- 00021

- CR

DEBORAH TIMMONS, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 114th District Court

Smith County, Texas

Trial Court No. 114

- 1126

- 10

Before Morriss, C.J., Carter and Moseley, JJ.

Memorandum Opinion by Chief Justice Morriss2 

### MEMORANDUM OPINION

Deborah Timmons , appellant, has filed with this Court a motion to dismiss h er appeal.

The motion wa s signed by both Timmons a nd h er counsel in compliance with the rules

. See

T EX

. R. A PP

. P. 42.2(a). W e grant the motion. See T EX

. R. A PP

. P. 42.2 (a)

.

Accordingly, we dismiss the appeal

.

Josh R. Morriss, III

Chief Justice

Date Submitted: March 5, 2013

Date Decided: March 6, 2013

Do Not Publish
Court of Appeals, State of Michigan 

ORDER 

Michele Mayer v Steven Glen Gregerson 

Docket No. 336850 

LC No. 2005-710435-DO 

Jane M. Beckering 

Presiding Judge 

Michael J. Kelly 

Colleen A. O'Brien 

Judges 

The Court orders that the order dated June 27, 2018 that amends the June 26, 2018 

opinion is VACA TED. 

The Court further orders that the June 26, 2018 opinion is AMENDED. The opinion 

contained the following clerical error: the case caption spelled petitioner-appellee's name as Trish 

Oleska Haas. The correct spelling is Trish Oleksa Haas. 

In all other respects, the June 26, 2018 opinion remains unc a ged. 

A true copy entered and certified by Jerome W. Zimmer Jr., Chief Clerk, on 

JUL 1 0 2018 

Date ~~~- 9-. 

Chie~
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in Local Rule

47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

__________________

No. 96-20283

Conference Calendar

__________________

DAVID DELEON RAMIREZ,

 Plaintiff-Appellant,

versus

R. G. BELANGER; L. A. MASTERS, Dr.; E. W. BROCK, 

Major; PATRICIA L. GEE; L. L. BREWER; M. B. THALER;

TIMOTHY MASSEY; GEORGE R. PIERSON,

 Defendants-Appellees.

- - - - - - - - - -

Appeal from the United States District Court

for the Southern District of Texas

USDC No. CA-H-93-2286

- - - - - - - - - -

August 20, 1996

Before KING, DUHÉ, and DeMOSS, Circuit Judges.

PER CURIAM:*

David Deleon Ramirez, #482200, appeals the district court’s

grant of summary judgment to the defendants-appellees in his 42

U.S.C. § 1983 civil rights action. The district court did not

err in ruling that Ramirez’s request for surgical relief for his

hernia was rendered moot by his 1994 surgery. See Powell v.

McCormack, 395 U.S. 486, 496 (1969). Ramirez has abandoned his

claim for the restoration of good-time credit. Yohey v. Collins,

985 F.2d 222, 224-25 (5th Cir. 1993). Ramirez’s motions “to
No. 96-20283

-2-

intervene” and for a temporary restraining order raise factual

questions for the first time on appeal and are denied.

AFFIRMED. 

MOTIONS DENIED.
Skip to main content

Privacy Policy•Site map

#  Other Forms and Instructions

A Guide for Self-Representation

Application to Proceed In Forma Pauperis 

Attorney Admission

Certificate of Service

Complaint Cover Sheet (Form 2, RCFC)

Pro Se Complaint Form

Fee Schedule

Guidelines for Cases Involving Classified Information

How to File a Bill of Costs

New Cases Involving the Addicks and Barker Flood-Control Reservoirs in Houston, Texas

Instruction Sheet for Filing a Complaint 

Notice of Appeal Form

Prisoner Authorization

Howard T. Markey National Courts Building • 717 Madison Place, NW, Washington, DC 20439 • 202-357-6400